Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Mol Genet Metab. 2015 Oct 26;116(4):269–274. doi: 10.1016/j.ymgme.2015.10.009

Table 2.

Patients with SAH hydrolase deficiency.

# Mutations Age of onset Sex Country of origin Liver Muscle Cognitive Ref.
1 W112X/Y143C <1 month M Croatia Hepatitis, hepatic fibrosis Hypotonia/weakness Delayed development [6]
2 W112X/Y143C <1 month M Croatia ? Hypotonia/weakness Delayed development [12]
3 W112X/Y143C <1 month M Croatia ? Hypotonia/weakness ? [10]
4 R49C/D86G <1 month (1 monthb) F USA (unreported ethnicity) Likely liver disease Hypotonia/weakness ? [9]
5 R49C/D86G <1 month (4 monthsb) F USA (unreported ethnicity) Liver disease Hypotonia/weakness ? [9]
6 Y143C/Y328D 8 months F USA (European descent) Elevated aminotransferases Hypotonia/weakness Delayed development [7]
7 R49C/G71S <1 month F Czech Republic Hepatic decompensation Hypotonia/weakness Delayed development [8]
8 Y143C/A89V <1 month M USA (unreported ethnicity) At 14 months: liver biopsy ➔ large lipid droplets Hypotonia/weakness IQ 64 at age 20 years [11]
9 R49H/R49H 23 years (32b) F Pakistan Hepatocellular carcinoma Weakness Low IQ
10 (R49H/R49H)a 3 years (35b) M Pakistan Cirrhosis Weakness Low IQ
11 (R49H/R49H)a ? (17b) M Pakistan Hepatocellular carcinoma Weakness ?
12 R49H/R49H Asymptomatic at 7 years M Pakistan Elevated aminotransferases Normal Normal

Cases 9–12 are described in the present report. Question marks indicate no information on phenotype available.

a

Mutations not determined, but likely to have been R49H homozygotes.

b

Died at indicated age.